[Methodological recommendations of the Regulatory Agencies]

Area of Science:

• Pharmacovigilance and Drug Regulation
• Clinical Trial Methodology
• Public Health Policy

Context:

• Health authorities and drug agencies evaluate new drugs for population use based on risk-benefit assessments.
• Regulatory bodies establish strict criteria for drug market entry and usage, focusing on quality, safety, and efficacy.
• Transparency is maintained through publicly available guidelines detailing these requirements.

Purpose:

• To review regulatory guidelines crucial for assessing drug suitability.
• To highlight common recommendations across drug approval guidelines.
• To provide a reference for clinical trial design, conduct, and publication.

Summary:

• Regulatory guidelines mandate appropriate methodology, traceability, verification, justification of deviations, and robust results.
• These guidelines emphasize practical aspects of study design, performance, and quality assurance in research.
• Key recommendations include a priori defined objectives and demonstration of results' robustness.

Impact:

• Ensures public access to safe and effective medications.
• Promotes high standards in clinical research and drug development.
• Facilitates informed decision-making by researchers, authors, and reviewers of clinical trials.